Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 15, 2019 - Issue 12
Submit an article Journal homepage
410
Views
11
CrossRef citations to date
0
Altmetric
Review

TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis

Ennio LubranoAcademic Rheumatology Unit. Dipartimento di Medicina e Scienze della salute “Vincenzo Tiberio”, Università degli Studi del Molise, Campobasso, ItalyCorrespondence[email protected]
View further author information
,
Silvia ScriffignanoAcademic Rheumatology Unit. Dipartimento di Medicina e Scienze della salute “Vincenzo Tiberio”, Università degli Studi del Molise, Campobasso, ItalyView further author information
&
Fabio Massimo PerrottaAcademic Rheumatology Unit. Dipartimento di Medicina e Scienze della salute “Vincenzo Tiberio”, Università degli Studi del Molise, Campobasso, ItalyView further author information
Pages 1303-1312 | Received 30 Jul 2019, Accepted 23 Oct 2019, Published online: 10 Nov 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xin-Yi Shao, Jian-Xia Xiong, Ai-Jun Chen, Kun Huang & Ping Wang. (2023) A Patient with Adalimumab-Induced Refractory Paradoxical Palmoplantar Pustulosis Was Successfully Treated by Ixekizumab: A Case Report. Clinical, Cosmetic and Investigational Dermatology 16, pages 879-881.
Read now

Articles from other publishers (10)

Silvia Scriffignano, Fabio Massimo Perrotta, Paola Conigliaro, Mario Ferraioli, Paola Triggianese, Maria Sole Chimenti & Ennio Lubrano. (2023) Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis. Rheumatology and Therapy 10:6, pages 1785-1794.
Crossref
Ana De Vicente Delmás, Lara Sanchez-Bilbao, Vanesa Calvo-Río, David Martínez-López, Alba Herrero-Morant, Eva Galíndez-Agirregoikoa, Iñigo Gonzalez-Mazon, Nuria Barroso-García, Natalia Palmou-Fontana, Miguel A Gonzalez-Gay, José L Hernández & Ricardo Blanco. (2023) Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review. RMD Open 9:1, pages e002781.
Crossref
Yan Xie & Yang Liu. (2022) Does previous use of tumour necrosis inhibitors change the therapeutic effect of interleukin ( IL )‐17 or IL ‐12/23 inhibitors on psoriasis and psoriatic arthritis? Results of a systematic review . Clinical and Experimental Dermatology 47:9, pages 1627-1635.
Crossref
Xuemei Tang & Ling Chen. (2022) The risk of organ-based comorbidities in psoriasis: a systematic review and meta-analysis. Anais Brasileiros de Dermatologia 97:5, pages 612-623.
Crossref
Kevin Díez-Madueño, Mariano Matarranz del Amo, Laura Cebrián Méndez, Diana Velázquez Tarjuelo & Pablo de la Cueva Dobao. (2022) Pancitopenia grave como reacción adversa al empleo de adalimumab biosimilar. Piel 37:5, pages 273-276.
Crossref
Thalita Basso Scandolara, Leticia Madureira Pacholak, Isabella Morais Tavares, Rodrigo Kern, Leonardo Garcia-Velazquez & Carolina Panis. 2022. Translational Autoimmunity. Translational Autoimmunity 15 49 .
Omer Karadag, Ediz Dalkilic, Gizem Ayan, Orhan Kucuksahin, Timucin Kasifoglu, Neslihan Yilmaz, Suleyman Serdar Koca, Veli Yazisiz, Pinar Talu Erten, Mehmet Sayarlioglu, Mustafa Ender Terzioglu, Sukran Erten & Umut Kalyoncu. (2021) Real-world data on change in work productivity, activity impairment, and quality of life in patients with psoriatic arthritis under anti-TNF therapy: a postmarketing, noninterventional, observational study. Clinical Rheumatology 41:1, pages 85-94.
Crossref
Paulo Sarango-Granda, Marcelle Silva-Abreu, Ana Calpena, Lyda Halbaut, María-José Fábrega, María Rodríguez-Lagunas, Natalia Díaz-Garrido, Josefa Badia & Lupe Espinoza. (2020) Apremilast Microemulsion as Topical Therapy for Local Inflammation: Design, Characterization and Efficacy Evaluation. Pharmaceuticals 13:12, pages 484.
Crossref
Holly Anderton, Ian P. Wicks & John Silke. (2020) Cell death in chronic inflammation: breaking the cycle to treat rheumatic disease. Nature Reviews Rheumatology 16:9, pages 496-513.
Crossref
Shiguang Peng, Mei Cao, Xiaoying Sun, Yaqiong Zhou, Chu‑Yen Chen, Tian Ma, Hongjin Li, Bin Li, Bo Zhu & Xin Li. (2020) Recombinant programmed cell death 1 inhibits psoriatic inflammation in imiquimod‑treated mice. International Journal of Molecular Medicine.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.